Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Foamix Pharmaceuticals Fourth Quarter and Fiscal Year 2017 Financial Results Conference Call & Webcast Scheduled for February 28 | ||||||||||||||||||||||||
By: Nasdaq / GlobeNewswire - 13 Feb 2018 | Back to overview list |
|||||||||||||||||||||||
REHOVOT, Israel, and BRIDGEWATER, N.J., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), (“Foamix”), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical foams to address unmet needs in dermatology, today announced that it will report its financial results for the quarter and year ended December 31, 2017, after the market close on Tuesday, February 27. Foamix will host a conference call and webcast at 8:30am Eastern Time on Wednesday, February 28.
About Foamix Pharmaceuticals Ltd. In addition, we have development and license agreements relating to our technology with various pharmaceutical companies including Bayer HealthCare and others. Contact: US Investor Relations |
||||||||||||||||||||||||
|
||||||||||||||||||||||||
Copyright 2018 Nasdaq / GlobeNewswire | Back to overview list |